NCT02940366View on ClinicalTrials.gov

Effect of High-dose Pitavastatin on Glucose Control in Patients With Metabolic Syndrome

PHASE4UnknownINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

December 1, 2016

Primary Completion Date

November 30, 2019

Study Completion Date

November 30, 2019

Conditions
Metabolic Syndrome
Interventions
DRUG

Pitavastatin 4 mg orally daily

Pitavastatin 4 mg orally daily for 24months

DRUG

Atorvastatin 20 mg orally daily

Atorvastatin 20 mg orally daily for 24months

Trial Locations (1)

Unknown

RECRUITING

Seoul National University Hospital, Seoul

Sponsors

Collaborators (1)

JW Pharmaceutical
All Listed Sponsors
collaborator

JW Pharmaceutical

INDUSTRY

lead

Seoul National University Hospital

OTHER